44 Sep. 1993, Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 I L VP Pq 1993 9 15-18 11 THE SECOND WORLD CONFERENCE ON ACADEMIC EXCHANGE OF MEDICAL QIGONG (Abstracts of presentations) Beijing,China 15-18 Sep. 1993 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 H *L ........... A I* A R 4t Z- 01 I~z ........................................... 1 2 L~C It 4K ~~ T I- TV ah~ 0, jVI-;6S t-j- *TLW4( - f Ti . ...................................................2 ) 1-3 ...... A. Dorigo *( 3 ) . ......................................................t* fH%(4) 1-5 ~k4,L ..........................................%Wf5f -% ( 4 1-6 kj-~~Q 41 4X ~~, T-%:01 O~ 0, 1 A YXI VRT~ Mfff tf TE 0, TM Z ................................. 4 5 I 7 JF,~ I-V [* f,~ Hf, Y)j & IN- ik ~CL TAJ)~ 6 - r,,j 0- U, a~ TU gkit VF 5~ .................. 1 8 -'f I t M JYj' it Xt'% A S T- M f N 1~ [Yj **1*4 6 - fjf 16 ....................................... I 9 j!4~- [N, ~& ..............................................................................R. H. Lee( - 7 I 10 ~Vrt A A rf, ~A t IN * ~n VI & 01 YZI Pl'.jJ~4~*4( - R 4 K $01 N i-It ........................... 7 1 11 ILC YA 0 ~1~1 xlt;a 11% Mil a A k1b" P* 4VT'M 8 - 0 B)f W f 0, A Aff 4~ ............... I - -jA W 4 Pil Pjj- f ~ m 01 TI)f A ........................AURV( 9 12 `7C Y)j ~,f -jkd~ Xi, 4 $j -~ ri F 1-13 TEfXT)jXtt* ........................... --% U 5P, 4 ( 9 I 14 #J,& jl~ jfl Ono ......................................................flj~ 9 - A 4 (10) 1-15 'LC A XT J~ 4-L I 4;~ OL Onin fYi I'-, OA T lv~% ff A .............................................(11) I _ ffr, .............................................WH] 4(11) 16 J):] jjq 7T i 17 j):j x~f, L, K x)j 'M 0, iu,,'~ nn,~ ............................................................RjNM (12) - 1-18 . ..................... !~ )&-%(13) 1 19 ;k fx -_V xf ~~ 9~ R 01 Mfl ............................................................-f~H)w - (13) 1 2 0 ~q )~`C X)j Y)i ~YL;RF A Z -- - 9111: A 11- w A IA IEI~ IIE M i~ OIL 9% 01 A JT ~-k J2-y- fl] ff A ....................................4 (14) 1 - t -'j Ift 0, r* tt .......................................(14) 21 'LC T)i JYJ ~J: NT - 1 - JJ'OC y"'IC Vj tZ Xt WL 1',J FU-i~ 43 IYJ ~V," n r-I 2 2 8~ Mf)V L M-,:,K &I M r MI-t j 'Ill XT M, yIj W Iz ................................................. H. Lee R 4 0 4) 1 2 3 N. It 0, f ~ * ff JZ .........................................................G. Gori - !;(15) 1 2 4 )Z- -= I E. A. V. +=f . ....................................... - V. Genitoni 405) I 2 5 44-1r /T,, t JZ -MJQII ft frj'~ T f- Off M. Sancier - 0, ........................... K. (16) 1-26 .............................. R. L. Anglen(17) Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 1-27 '~2C JYI Xf, r1 t~ V6 P ni . .................................................................. ik S )~4 (17) 1-28 ff~~ ......................................................T--fKA (18) 1 - 2 9 A t")J)A A 4z~ W # 0~ f P -A .................................A )Eja4N; (20) 1 - 3 0 ffi`C:~h X;T t I t ~,4,1 Pn. ot ff ~6 &A ft 4 (20) .......................................... 1 - 3 1 Xf -1 #j ~j r2y 0, ff 16 .............................................~kll H~~4(21) (2 1) I - 3 3 /J" 11 OA M lrf~ M~ ff ~~L ......................................................... 1-34 $qV-jfl ........................... 1 - 3 5 1E ~6 ........................... 2 4 1-36 M Mi Fk NJ MI 11,N~'VO 0,) A~'x . ................................................ . M -W -4 f 2 4 I - 3 7 '%:rt Xt A r t * R YL [YJ f~- Jfl ...........................PE fX FN LE,K FP,rt +A M N 4 4~- (2 5 1 - 3 8 : rt C Y-t rf 4 m Lu A F ~ 4 TJR fyi P 0, % If , f I -- ffl ........................ jm mW26) 1-39 .................. Atft4V(26) 1-40 (BEL - 7402) ...............................................................[Y/fj~,Fx~ (27) 1-41 kv '11i- f~j ff Iz .....................................................................P/~,j~Tx~ (27) .................. -WAj~4(28) .................. it -1; ( 2 8 ) 1 - 4 4 Tjj Xf A b~' ON Q ~M & f* IT, R~)A rm W, /1" R Wj xx rf i4 -qA& ........................... 4 (2 9) 1 - 4 5 Tjj */-C Xf JIM"rM t K, 0 4 R T4 I rp R4~-P*400) A H~j I'v]i p"~ Prij (~,j 2Y,- _0 fff ~~L ............... I - 4 6 xt ~* ~~=-C Xfij, PK ~r~ ~jW PJi-Mw ~-?kA A! j~k T, 0, ~911,, V, (Z -) .................................!~ 0 0) I - 4 7 1% Xt /1, FK M 0, ~q I Q 0, ~", rT f R4~r-*401) ~ jtj ................................................ I - 4 8 T)~ 1% ~'fl N !)L 9E f ~ f~,j ~~ fl- A5 n ~+-, ~M %:rjj /C 0, W)f T6 ...........................4 (3 1 I - 4 9 FK W TQ Ili 01 1 K ~M j M, r)t Wk~ hh ~~ N 4 0 JN M N f~)fl (ADCC) 14j~ nr-] 0, ff J~ ................................................JWI MV02) y- M /1, JiW. 9,~ &:t Rk (~j 1.9 t~ jj~-M ....................................31~ fl-H402) 1 - 5 0 XT r 1 - 5 1 T)~ jfl Wj ~)T, V. ................................................X5 3V 3,4- ( 3 3 .............................. 33) 1-52 k4 v- rw X- R V q r4 R m .. ........................................................................... Oqigg!~04) I - 5 4 /~~C Yt 4~~C Xf fj,,Y, f ~) E 0, ~-I Pfr, th 4 i9 & ff A .......................................(35) ....................................... r,/~,FqA (35) . ....................................... LX LrIM36) I - 5 7 Xf -A A C #V~4 ti't 0, HN .......................................T * 4 0 6) 1-58 DNA ZA~fF9~ ..............................................................................P~~-407) 2 - Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 ~~ 0, ~)f ~~ ......................................... I - 5 9 Xf V,[~- 0 9A X FO ~~"k r I - 6 0 ~~ YJI 9* ff M, M A Ij -9,~ Vq ......................................................... (38) TA ma,~- 2. 41 2 -1 51111t~ vq f~ 14 01 z 1~ I ........................................... 2-2 2 4 2 ti FrLIJ ~rj 3 0 4-- M tq ...................................................~H~ff 109) 2 - 3 =C rA xf A A mi *E W V BR -** k V M 0, W- &, ~~ ~6 ....................................... * (4 0) 2 - 4 A IME ~N ft A Frh R M f A, Ax ffilt 0, -V *AM14(41) . .................................... 4-L & ffj f rm W MI V, . ..............................$N)CA4(41) 2 - 5 4 ~ I ni MA irprT 15 8 riq WN zi 2 - 6 '~ECY)MMY 1q, kt -Pj IL &,- 3 0 PI ................................................ C. Bornoroni (42) -VA .........................................................(42) 2 - 7 A A FE A4,110, 9t: Vj F,: 1 2 - 8 rT 2 1 fYq ff ftjj 0, jFx 'IL . .........................................................(4 2 4 r-t 2 - 9 A P~ ft rr 9- it 3A Of & It' ~rl A 4* w1i 4(43) t, ) 4E X)j ft .................................... -tEO, GWYM .............................................4 ( 4 2 - 10 `~C rT )I% r 4 k ft V . .............................................0- J)"L 2-11 VftV:CX)JMjY 122 VqPWY~ M4 (44) 2 - 12 TY 3 0 V~ OM rhH Irpi M~ NO V . ......................................................T- '-k (45) M f,4~i(45) -k ..................... 2 - 13 N N,`-C VI " ~fn` ifiTT? W, -A 12 0 fr)q I r[~ r* kOK 4-*'JY ~'~ 2 - 14 Mkq'~p'~Y ................................................11MA (46) 2-15 AtgaO, K*Y-q"ih"O K* ......................................................IM- [Z-06) x I L M' ff A 7 5 Vq I r~i MJM ..........................................'~tNL64(47) 2-16 'L-C:,rtff"rr'r-'V 2 - 17 M 4A ~rj ~Y 0, YY7,)j!j ( N M1J ) 3 1 fFjq)AM -T-, Y ~A Alu V . .......................................J+ 4 (4 8 ) 2 - 18 04 ~I EMT L=C ft A 71-~ t/-v '-N"- 5 2 HA~f. r941 rj,'l W /j~ $R .......................................(48) 2 - 19 Yt Vp) Y 2 6 7 4r) q ~)j r[4 I rr i W, 7J~A~- 3~ W .......................................... (49) -,Wfy- ,kMV . ...................................................VE 4W 2 - 2 0 ~ftj YY P?, M rM ~ Y 4 9 2 - 2 1 It r)-LJK:t 0, 1 rM)~,;* ~6 ............................................................4y 4 5 0) 2 - 2 2 /A-, rT M V I -rih yIj 4* A-1/1 . .......................................z1fqVP (50) 2 - 2 3 `L~ -01 ~rrj'~Y`C ~w" th jk~& ALA 6 0 'r)4 rr ....................................... MUrj, 'uv, (51) 2-24 . ........................... . t~CFTI (51) 2-25 9 . ........................... . T,,tA401) 2 - 2 6 ...................................................4 4 ( 5 2 ) A t (53) .................................... 2 - 2 7 ~,j -T~ /=C J)~ I f n ~k m rf 2 - 2 8 1)1 WV -Lj)!~~ Jfl ................................................~Jkgrj 4 (53) IWRYM~ ........................... #~tA (54) 2 - 2 9 4,j'Y' Vr' 1 M f4 49 rYj InN Ar .................................Y. Z. 2 - 3 0 ~,t 10 0 rF. ~~- Fu (5 5) 2 - 3 1'6 r 6rKj (Pvt ffl, Tf L 4~t ~V V ....................................5 6 fl TIR f~ ~,f /:~XCWTT IYU ab~ ........................................ Enrico B. K (5 6) 2 - 32 'Wr 2 - 3 3 /~C A TP A M WWj .....................................................................=,bL" 5 7 3 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO04004300bl -6 3. 4 46 ft OL 9 fe',,At t 3 - I t Liij N )'I *. ~b ~N f H ilk .................................................................. I;'rJA-WJ (58) 3-2 ............................................................ -TAM4(59) .. ......................................................... IZ,-k ft, 4 (6 0) 3 - 4 'LC Y)J)2-: I:P ff- 0, - r-j JR 7, 3~ ~Z ................................................... kX- M t (6 0) 3 - S -~: )~ -r-- ~t r~~ ......................................................................... kX- -4 Xf~ 4 (6 1 ) 3 - 6 T, -Ij ±J~ " I tj ~k ............................................................... T/M*Ot (62) 3 - 7 j'rj'rT ~ -M *. ............................................................ TW4 (63) 3 - 8 VP Fq J-~ 9A J.9 )~ Y)] f H A Wf M' -W 14 .......................................... ~~ A (64) 3 - 9 gh -Ut ................................................ LX it 3-1- 4 ( 6 5 3 - 10 J):j .............................................................................. j0-( A (65) 3-11 .................................................................. 91220 (66) - 4 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 CONTENTS 1. Basic Research and Experiment page 1-1 META-SYNTHETIC INVESTIGATION INTO HUMAN SOMATIC EIGEN- STATES ..................................................................67 Yu Hefeng et at 1-2 DYNAMIC CHARACTERISTICS OF PHYSIOLOGICAL CHANGES UNDER THE QIGONG STATE .............................................68 Song Kongzhi et at 1-3 ON HEALTH CONSIDERATIONS TO PROPOSE A MODEL DETERMINED BY MODERN CHEMICO-PHYSICAL BASES TO UNIFICATE THE ABIOT- IC WITH THE BIOLOGICAL WORLD ..................... Antonio69 Dorigo et at 1-4 A SCIENTIFIC STUDY OF THE PRINCIPLE OF HEALING BY QIGONG ....................................................................................71 Kazu Mori et at 1-5 THE INFLUENCE OF QIGONG TRAINING ON COHERENCE OF EEG DURING ONE YEAR PERIOD .............................. 72 Yang Sihuan et at 1-6 MEASUREMENT OF PHYSICOLOGICAL PHENOMENA AND OTHERS OF QIGONG MASTERS UNDER THE QIGONG STATE ............ Yoshio73 Machi 1-7 A STUDY OF THE POSSIBILITY OF PUSHING BLOOD FLOW TOWARDS THE HEAD AND CHEST IN THE LYING POSITION WITH THE HEAD ON A LOWER LEVEL DURING QIGONG EXERCISE ............ Hou 74 Shuli et at 1-8 THE STUDY OF MAGNETIC SIGNALS UNDER THE QIGONG STATE BY SUPERCONDUCTING BIOMAGNETOMETER ............... Wu Benjie75 et at 1-9 KIRLIAN IMAGING-VISUAL INVESTIGATIONS INTO THE NATURE OF Q1 AND THE EFFECTS OF QIGONG ........................76 Richard H. Lee 1-10 INFLUENCE ON THE VEGETATIVE FUNCTION AND ITS MECHANISM BY BREATHING HARMONIZATION ........................ 77 Zhang Jinmei et at 1-11 A STUDY OF PREVENTION OF CARDIAC FUNCTION DISORDER DUE TO IMMEDIATE ENTRY INTO HIGHLANDS BY QIGONG EXERCISE ...........................................................................78 Mo Feifan et at 1-12 A STUDY OF PREVENTION OF MICROCIRCULATING DISORDERS OF PILOTS IN HIGHLANDS BY QIGONG ...........................78 Mo Feifan et at 1-13 A STUDY OF THE INFLUENCE OF YUAN JI QIGONG ON PHYSICAL AND MENTAL HEALTH OF STUDENTS .................. Wu 79 Hanrong et at - 5 - Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000108115: CIA-RDP96-00792ROO0400430001-6 1-14 INFLUENCE OF MENTAL ACTIVITY ON THE RESPIRATION REGULA- TION DURING QIGONG EXERCISE ..............................80 Sun Fuli et at 1-15 EXPERIMENTAL RESEARCHES ON QIGONG' S EFFECT ON THE DI- GESTIVE TRACT .........................................................81 Yu Min et at 1-16 A STUDY OF QIGONG,HARMONIZING THE HUMAN CIRCULATARY SYSTEM ...............................................................82 Bao Guojing et at 1-17 THE EFFECT OF QIGONG ON THE HEART FUNCTION .................. ..4 ..............................................................................83 Huang Zuofu et at 1-18 THE EFFECT OF THE STEP-LEAP RESPIRATION ON THE CARDIO- VASCULAR FUNCTION UNDER THE ANAGOLOUS QIGONG STATE ..............................................................................84 Niu Xin et at 1-19 THE EFFECT OF TAIJIQUAN ON MERIDIAN WAVES ..................... ..............................................................................85 Mao Mingchun et at 1-20 A STUDY OF THE DETECTION OF CHANGES IN METABOLIC ENERGY IN A SUPERFICIAL ACUPOINT OF QIGONG EXERCISERS AND ITS CLINICAL SIGNIFICANCE ..........................................86 Feng Lida et at 1-21, INFRARED PHENOMENA UNDER THE QIGONG STATE AND BLOOD VESSEL VOLUME ...................................................86 Chai Jianyu et at 1-22 USE OF SURFACE ELECTROMYOGRAM TO EXAMINE THE EFFECTS OF THE INFRATONIC QGM, ON ELECTRICAL ACTIVITY OF MUS- CLES,A DOUB[,E-BI,IND,PLACEBO-CONTROI,LED STUDY ............... ...........................................................................87 Richard H. Lee 1-23 SCIENTIFIC RESEARCHES ON MEDICAL QIGONG VOCALISATION ... .............................................................................88 Gilberto Gori et at 1-24 STOMACH VOCAL SOUND STIMULATION AND E. A. V. MEASURE OF ~ZUSANLI(ST 36) ......................................................89 V. Genitoni et at 1-25 THE EFFECT OF QIGONG ON THERAPEUTIC BALANCING MEA- SURED BY ELECTROACUPUNCTURE ACCORDING TO VOLL(EAV) .....................................................................90 Kenneth M. Sancier 1-26 QIGONG: BALANCING BIO-ELECTRICITY BY BREATHING BEFORE BIO-KINETICS ......................................................91 R. Lindsay Anglen 1-27 THE EFFECT OF QIGONG ON PERSONALITY ............ 92 Tang Cimei et at 1-28 THE ROLE OF QIGONG ON MENTAL HEALTH ............ 93 Wang Jisheng 1-29 A SURVEY OF INTERRELATION BETWEEN QIGONG CONCERNING 1-23 FACTORS OF INTELLIGENCE AND PERSONALITY IN YOUNG PEOPLE ...............................................................95 Liu Tianjun et at 1-30 INFLUENCE OF QIGONG FOR INTELLIGENCE ON UNIVERSITY STU- DENT MEMOR~ . ......................................................95 Pan Keliang et at .6. Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 1-31 A STUDY OF THE BIOLOGICAL EFFECT OF THE EMITTED Q1 ON MICROBE ..................................................................96 Liu Zirong et at 1-32 A COMPARATIVE STUDY OF THE EMITTED Q1 AND PHYSICAL- CHEMICALFACTORS ON THE PROTOPLASMIC MUTAGENESIS OF MICROMONOSPORA ECHINOSPORD ........................ 97 Liu Zirong et at 1-33 THE REPEATED EXPERIMENTS BY USING THE EMITTED Q1 IN TREATMENT OF SPINAL CORD INJURY .................. Wan 97 Sujian ct at 1-34 MODIFIED EFFECT OF THE EMITTFD Q1 ON CLOSE-OPEN KINETIC PROCESS OF SODIUM CHANNELS OF RAT CULTURAL NEURON. CELL ........................................................................98 Liu Anxi et at 1-35 SPECTRUM ANALYSIS EFFECT OF THE EMITTED Q1 ON EEG OF NORMAL SUBJECTS ................................................98 Li Desong et at 1-36 QIGONGS SUGGESTIVE EFFECT SEEN IN EEG .............................. ........................................................................99 Kimiko Kawano (Japan) 1-37 THE EFFECT OF QIGONG ON EXPERIMENTAL INFLAMMATION AND NEUTROPHIL CHEMILUMINESCENCE ..................... Yan 100 Yizhao et at 1-38 PROTECTIVE EFFECT OF THE EMITTED QT ON THE PRIMARY CUL- TURE OF NEUROCYTES IN VITRO AGAINST FREE RADICAL DAM- AGE .....................................................................100 Tang Yipeng ct at 1-39 THE EFFECT OF THE HUMAN ENERGY FIELD UNDER THE QIGONG STATE ON THE STRUCTURE AND FUNCTION OF RED BLOOD CELLS IN EXPERIMENTAL RATS WITH BLOOD STASIS Liu Chunmei et 101 at 1-40 ANALYSIS OF THE EFFECT OF THE EMITTED Q1 ON HUMAN HEPA- TOCARCINOMA CELL (BEL-7402)BY USING FLOW CYTOMETRY ...... ........................................................................102 Chen Yuanfang ct at 1-41 THE EFFECT OF THE EMITTED QI ON AGGLUTINATING REACTION OF HUMAN PULMONARY ADENOCARCINOMA CELL (SPC-AL) MEDI- ATED BY CONA ................................................102 Chen Yuanfeng et at 1-42 INHIBITION OF HUMAN NASOPHARYNGEAL CARCINOMA CELLS IN VITRO BY THE EMITTED Q1 AND 7-RAY .................. 103 Cao Qiyuan et at 1-43 A PRELIMINARY STUDY OF THE EFFECT OF THE EMITTED Q1 ON EXPERIMENTAL ANIMALS INFECTED BY PNEUMOCYSTIS CARINII ........................................................................103 Zhang Jinmei et at 1-44 THE DOUBLE-BLIND TEST OF THE EMITTED Q1 ON TUMOR FORMA- TION OF A NASOPHARYNGEAL CARCINOMA CELL LINE IN NUDE MICE ..................................................................105 Chen Xiaojun et at 1-45 AN EXPERIMENTAL RESEARCH OF THE INFLUENCE OF THE EMIT- TED Q1 ON CANCER GROWTH, METASTASIS AND SURVIVAL TIME . 7 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 OF THE HOST ..........................................................106 Qian Shusen et at 1 -46 THE EMITTED Q1 ON MICE TUMOR PREVENTION AND TREATMENT .................................................................................106 Feng Lida et a] 1 -47 THE CURATIVE EFFECT OF THE EMITTED QI ON MICE WITHM04 TUMORS ...............................................................107 Qian Shusen et at 1 -48 A RESEARCH ON THE EMITTED QFS EFFECT ON THE IMMUNE STICKING FUNCTION OF RED BLOOD CELLS TO TUMOR CELLS ... ............... ...........................................................108 Feng Lida et at 1 -49 THE EFFECT OF THE EMITTED Q1 ON THE CHANGE OF ANTIBODY DEPENDENCE CELL-MEDIATED CYTOTOXICITY (ADCC) OF K CELL OF MICE CAUSED BY INJURY OF THE LEFT AND RIGHT BRAIN COR- TEX ........................................................................109 Zhou Yong et at 1 -50 THE ADJUSTING EFFECT OF THE EMITTED Q1 ON THE IMMUNE FUNCTION OF COLD-STRESS MICE ...........................109 Zhang Li et at 1 -511AN OBSERVATION OF THE EFFECT OF THE EMITTED QT ON THE GROWTH OF MICE ...................................................110 Feng Lida et at 1 -52 THE EFFECT OF THE EMITTED Q1 TO ACUPOINTS ON SOMATOSEN- SORY EVOKED POTENTIAL RECORDED FROM THE CORTEX FOL- LOWING ZUSANLI(St 36)STIMULATION IN CATS ........................... ................. .......................................................111 Cui Rongqing et at 1 -53'BASIC EXPERIMENTS OF ACTIVATION OF SEED GERMINATION AND GROWTH WITH THE EMITTED Q1 AND ANALOGOUS INSTALMENT OF THE EMITTED Q1 ..........................................112 Nakasato Seiki et at 1 -54i THE IR STUDY OF HEAVY WATER TREATED BY THE EMITTED Q1 .................................................................................113 Ye Fangyang et at 1 -55 THE MATERIAL EFFECT OF MIND AND Q1 -A RESEARCH WITH THE HELP OF THE LASER LAMAN SPECTRUM ANALYSER ............ ...........................................................................113 Chen Guoguang 1 -56 THE EFFECT OF THE EMITTED Q1 ON THE CHEMICAL SHIFT OF AC- TIVE PROTON .........................................................114 Zhao Jing et at 1 -57 THE EFFECT OF EMITTED Q1 ON THE HIGHER TEMPERATURE-SU- PERCONDUCTIVE MATERIALS ..............................115 Huo Yuhua et at 1 -58i A STUDY OF THE HYPERCHROMIC EFFECT AND HYPOCHROMIC EF- FECT OF THE DNA UNDER THE EFFECT OF THE EMITTED Q1 AND THE WILL ...............................................................116 Li Luying et at 1 -591 THE EFFECT OF THE EMITTED Q1 ON THE REACTION OF MALATE DEHYDROGENASE .............................................116 Zhang Fengde et at 1 -60 THE FUNDAMENTAL OF QIGONG ANESTHESIA AND EXAMPLES - 8 - Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 ....................................................................................... Yoshimi Inosuke 117 1-61 THE RELATION BETWEEN DIFFERENT STAGES OF QUIET QIGONG EXERCISES AND ITS INFLUENCE ON THE ELECTRICAL FIELD AROUND ACUPOINTS ........................... Marcus Bongart et al(Sweden) 117 1-62 THE SIGNIFICANCE OF INTERDISCIPLINARY COLLABORATION FOR STUDYING THE SCIENCE OF QIGONG AS THE CORE CURRICULUM IN AN INTEGRATED, CROSS-CULTURAL STUDY OF CHINESE HU- MAN /ENVIRONMENT RELATION, CULTURE AND ART ............... ........................................................................... Carl H. Hertel 118 1-63 A STUDY OF AAPPLICATION OF COMPUTES TO QIGONG ENERGY ........................................................................... Guo Deyuan 121 2. Clinical Study 2-1 MAKING FURTHER ADVANCES OF THE PUBLIC HEALTH CARE FOR THE AGED WITH CHINESE CHARACTERISTICS ..................122 Feng Lida 2-2 EFFECTS OF QIGONG ON PREVENTING STROKE AND ALLEVIATING THE MULTIPLE CEREBRO-CARDIOVASCULAR RISK FACTORS- A FOLLOW-UP REPORT OF 242 HYPERTENSIVE CASES FOR 30 YEARS ..................................................................123 Wang Chongxing et at 2-3 A STUDY OF THE RECUPERATIVE FUNCTION OF QIGONG ON HYPER- TENSIVE TARGET IMPAIRMENT ..............................124 Xu Dinghai et at 2-4 A STUDY OF QIGONG ON HYPERTENTION AND REDUCTION OF HY- POTENSOR ............................................................125 Wu Renzhao et at 2-5 CLINICAL OBSERVATION ON THE TREATMENT OF 158 CASES OF CEREBRAL ARTERIOSCLEROSIS BY QIGONG ......... Liu Yuanliang125 et at 2-6 TREATMENT OF 30 CASES OF PRIMARY HYPERTENSION BY QIGONG TECHNIQUES ................................................126 Corrado Bornoroni et at 2-7 PATIENTS OF HYPERTENSION SHOULD EXERCISE QIGONG CARE- FULLY .....................................................................126 Hou Shuli et at 2-8 A REPORT ON 21 CASES OF KIDNEY DISEASES TREATED BY QIGONG .................................................................................127 Lu Guangjun et at 2-9 THE EFFECT OF SELF-CONTROLLING QIGONG THERAPY ON THE IM- MUNE FUNCTION OF CANCER PATIENTS ............ Zhang 128 Rongmin et at 2-10 A CLINICAL STUDY OF THE ROUTINE TREATMENT OF CANCER CO- ORDINATED BY QIGONG ................................. 129 Wang Shouzhang et at 2-11 CURATIVE EFFECT ANALYSIS OF 122 TUMOR PATIENTS TREATED BY THE INTELLIGENCE-QIGONG ........................ 130 Zhao Hongmei et at 2-12 CLINICAL OBSERVATIONS ON 30 CASES OF CANCER TREATED BY .9. Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 QIGONG THERAPY ......................................................... Wang Ying 131 2-13 CLINICAL IMAGE EXAMINATION TO SEE THE CURATIVE EFFECT OF 120 CANCER CASES TREATED BY CHINESE-WESTERN MEDICINE AND QIGONG THERAPY ................................................... Lu Zhong 131 2-14 TREATMENT OF ADVANCED GASTRIC CANCER IN THE AGED BY THE COMBINATION OF QIGONG AND MEDICINAL HERBS ............ ................................................................................. Fu Jingzhi 132 2-15 FROM MEDICINE OF ORGAN TO MEDICINE OF FIELD - 10 YEAR EX- PERIENCE OF APPLICATION OF QIGONG TO MEDICAL PRACTICE .................................................................. Ryoichi Obitsu (Japan) 133 2-16 THE CLINICAL REPORT ON 75 CASES OF CHRONIC HEPATITIS B TREATED BY QIGONG ................................................... Shen Fudao 134 2-17 OBSERVATIONS ON EFFECTS OF 31 CASES OF DIABETIS TREATED BY HUICHUGONG ................................................ Jing Yuzhong et al 135 2-18 THE TREATMENT AND CLINICAL ANALYSIS OF QIGONG SIDE-EF- FECT .............................................................................. Lu Lijiang 135 2-19 A CLINICAL, ANALYSIS OF CERVICAL SPONDYLOPATHY AND ITS REHABILITATION BY TUINA QIGONG IN 267 CASES ... Li Xingguang 136 2-20 QIGONGS CURATIVE EFFECT ON LUMBAGO AND JOINT PAIN ...... ................................................................................. Huang Xiaokuan 137 2-21 A CLINICAL STUDY OF THE ANTI-AGING EFFECT OF QIGONG ...... ....................................... i............................................. Xu Hefen et al 137 2-22 BIOHOLOGRAPHIC QIGONG, DIGITAL PRESSURE THERAPY IN THE TREATMENT OF ACUTE CASES ....................................... Li Jianhua 139 2-23 THERAPEUTIC EVALUATION OF 60 HEADACHE CASES DUE TO STAGNANCY OF Q1 AND -BLOOD TREATED BY QIGONG ............... .............................................................................. Jiang Hansu 139 2-24 A REPORT ON THE PREVENTION AND CURE OF YOUNGSTER HYPROMETROPIA BY QTGONG .............................. Huang Wengguo 140 2-25 PRELIMINARY OBSERVATIONS OF 9 CASES OF SJOGREN' S SYN- DROME TREATED MAINLY BY "KONG JING CONG .......................... ............. ........................................................ Yue Zhaosheng et al 140 2-26 SEVEN TESTS OF THE YUAN JI GONG APPLIED TO DEAF-MUTE TREATMENT .................................................... Zhang Zhixiang et al 141 2-27 MONILIASIS TREATED BY THE EMITTED Q1 AND ACUPUNCTURE THERAPY ......................................................... Chou Chu (Canada) 141 2-28 DEVELOPMENT AND APPLICATION OF A SERIES OF QIGONG FEED- BACK TAPES ...................................................... Zhang Guifang et al 142 10. Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 2-29 HEALING WITH Q1 ENERGY MUSIC ON MAGNETIC TAPE ............... .............................................................................. Jack Lin(Australia) 143 2-30 A SURVEY OF 100 DOCTORS USING SIMULATED QIGONG IN THE USA ..................................................................... Yuan Zhifu (USA) 144 2-31 A STUDY OF THE TREATMENT FOR SLIPPED DISK ........................ .............................................................................. Kozo Noda (Japan) 145 2-32 CHRONIC SOFT TISSUE INJURY RESPONSE TO QIGONG THERAPY .................................................................. Bonny K. Enrico et at (USA) 146 2-33 THE BASIS OF QIGONG NURSING .................. Komatsu Hirochi(japan) 147 2-34 THE LUOHAN SYSTEM OF QIGONG ........................ G. Garcia (Spain) 147 2-35 EIGHT FORMS-QI-THERAPY ......... Lee Kang Yuan(Rcpubtic of Korea) 148 3. Research on Qigong Theory 3-1 THE THEORY AND METHOD OF THE TRADITIONAL TRAINING OF THE BODY INTERNAL FUNCTION .......................................149 Fu Liqin 3-2 INFLUENCE OF THE STUDY OF THE " BOOK OF CHANGES " ON QIGONG ........................................................................150 Wang Keqin 3-3 ZA BING YUAN LIU X1 ZHU (ON DISTINGUISHING INTERNAL DIS- EASES)-AN EXPLORATION OF THE ANCIENT QIGONG ............... ...............................................................................150 Song Tianbin 3-4 QIGONG, AN INDISPENSABLE BRANCH OF TRADITIONAL CHINESE MEDICAL SCIENCE ................................................151 Zhao Bangzhu et at 3-5 XUAN GUAN AND XUAN GUAN EFFECT .................. 152 Zhao Jicheng et at 3-6 ON ORIENTAL ENLIGHTENMENTOLOGY &. THE WAY OF ROOT-BACK .......................................................................................154 Sun Zexian 3-7 EXPLORATION ON THE TREATING EFFECT OF QIGONG MUSIC ...... ....................................................................................155 Wang Wantao 3-8 THE LEVEL OF CIRCLE OF Q1 .............................................155 Luo Sen 3-9 THE DEVELOPING TENDENCY OF CHINESE MEDICAL QIGONG IN CONTEMPORARY TIMES .......................................156 Zhao Lianting et at 3-10 PRACTISING QIGONG AND CULTIVATING MY MORAL CHARACTER .......................................................................................157 Zhao Guang 3-11 A BRIEF ACCOUNT OF DAOYIN QIGONG ...........................157 Qiu Jiling . 11 . Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 m -A Selected Paper Titles 1. L( xjj -Ej ~h m ......................................................... H. FABRE - RINGBORG PIGONG AND FRANCE .............................. H. FABRE-RINGBORG (FRANCE) LL . ................................................... 2. R P ~M ft ~~;Z -:f ( Ff 1~ EPORT ON POPULARIZATION OF REJUVENESCENCE PROCESS IN JAPAN ................................................... HARA TAEKO (JAPAN) 3. i,~~ JM .................................................................. i x 1w i~ 4 (rp 14) THE PROCESS OFHEALTH CULTIVATION OF "HUI CHUN GONG" ..................................................................... SHEN XINYAN ET. AL. (CHINA) 4. 1~ V Vj Ap~~'T 4~ M ............................................................ REJUVENESCENCE PROCESS BESTOWS SECOND YOUTH ON ME .................................................................................... SHOZO UEDA(JAPAN) /-\ --r- a I: ~ v] ................................................................................. X * ~h ( m, a--- ) LIU ZI WU XING GONG .......................................... L1 YURONG (HOLLAND) 6. ---y jn, . R~ (RIA . ........................................................................ 91% P Z At ( H YOSHIM11 S RESPIRATION METHOD - 1 2 - Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 All, rITI-m"AAF 5E *-T-fl~ff A PJ~, I L3~r, 100094, FPIM f* ** 0' Mit t fH"4 I A W*, V - -V-', JJ 2. Xf 202 0 OK, `%Vj, OWI;T, P] 4k~~R P~ # Y,' na ft-F AIT VV2# 1408 k&V34% HN t,~, iD ~IWH Mil I ~111- kfoll-0-1 01 ilt ~5-1 itlt. rrix W * A A 4x- ~~ ~~- -da 01 tt N-)(j xf M, ~~kMFM ~p AJIMR-M 0, -401, -L, MAIG- xf 1/,~ 44n, U-,3~ PI Af~-,tZ, 9~ 0, YN t~ ~T, N FOrg km, 5~ 9MA, f 11 M A; RftWA&Aff 4. M" fl)j -If M-1 a I RE W~V- A A; IyIjwIAIr0XHMI I] I*Ifk,*, ~k~H 2~ NJ 0, kfft, ~j t ff1fl, fj% 2 - 3 9f [~j -jYT 0, f-, ~AfH ~~ rHI; fV1 INKOW if AL A L 0 Jf-, ~t V ~~ r"I IP M - t I A A REE ; f R ~~ ~( To L* U m I A% RE A ~AW~PIFPOI IA W, 4 A 01 1 LZ~AU IIII& A fuNOWIM I L~ /R fl~,- th", VTI Wr a Rq w1i I YV A ~X 4, A 4 JA,'it * A 9 & Lb VL 4 0 1 A fR RE 4k ~~ ~fl n 911 ~N n 3j~f P M FP 1YIJ 4X t+ ff f H f-, ~J6 ~ L- YAJ ~j JjE W 4;:Tt ~ Off A A-,, A jL w A )\, 4 5i! 01 41 RE 4)~ 5. jW 3k A 0, - 4k J~ Mr-, ~%)A W ~k , Pf N g gu it , ~L ~, I Jt , T% -,4 4 * ~iF -h W f~r A * ff f-, ~A Pff 0, 1 A RE 4K ~5; 1~ T- ~-k 91 A 0 JO I RE- R-;L-; T-, F-I Vj RE R ~L M, 0, f ~- 1% #L M ; N R A V -"j IjL 1 A. -0 - J~ Pri 0 6. T)j (6 ff 4: E, Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000108115: CIA-RDP96-00792ROO0400430001-6 1 - 2 &L It- 4* 6T -F I i-T &)~j D. M 6% % ~!E 5OLY ELI# WOM )h,-kEK*T-fIff 10W 100094, FP [A Qu Wj ~* I- _~j`~i( I W 9 6 -'~ RL ~4 2 - 3 *- Y)j ri. * P~ 15 ;t RP P T;ti -T-!v -n, , 30 & IR *1 P11 ~~( It 4K. ~~ 4H xf T-[Y# A H-11 - P~ 4)~ ~5 0j, V kf i~, t ( YO 1 ft x1t PI, 91L ~L V /~t ill, -=q-:xt*`EC A 9A A z-VrPO, UVIPO, -nm] -Lyt!A~I~ a it f L # I T~ ~-k A : t ~~ #1 tl~ I i~ /,'Q I$M ; I /"~, A -7~, IA- ~fi , ff 1 t J'Q)~,L Trr fft A 14 4~ IM $q I I "IN-, I fm 01 1 Iq ~P $q f ft A 111; 1 15(If "A- V~ M x1f A I~f . ILI~ Z I A tr & f ~ A T- I it w 01 1 a rD2~-A A !~:;dvrp it AL a I IA iIjyxf* Ifff-V (~PW It V", Tif fij-,4VV~4 ri -ff f )FLI, HJ4 a, lyj -J,~ -riv, 91p: f)] 911 Wj Mli, X,~t -1 J-~ _Pf Lk 4 9. 0 ± 6. 4 ( Yo 3 Xt M 9JI)rJq T-E 16. 7 ± 2 8. 3 ( Yo ) 0, 71~ T- ti 4Y ~ k * HA -,10, ~k it * A ~11 . M- Ht, ff-, R YIJ , I, ~2-, V 1P 3L, A -Of PJ JQ~ K, I Ut MI, 6 d b 0, Wj fi~" -1 IP H- HI, Mil j~ ff ~k f n fM- &A0, IM M -L 4 VJ TM 2 5 78. 1 YO I ~If Pq, 9E V - n ff I T V~ f ff- A N 3 2 P -4 5 2 TIQ 01 1 ff. r"i Hf, JYJ 4K- ~~ T- I & F-b IFM 109 RI ffl N 1 -9 M~ - # VIj ~~ ft i~ 11. - 2 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 1-3 41*0 -151vttfMll fSAM-4-1i Antonio DOR1GO(1),9c3rzWW (3), Corrado BORNORONI (2), Giovanni GATTI(l), Gilberto GORI (1), Valerio GENITONI (1), *BA SA (3), Giulia BOSCHI(4),Valdo PASELLO(5), Maria Teresa TONELLI (5), Vittoria FAVARO(5) (1);KR, ~LO:k* N* N?P~qfvl~~*R n A#L* Px-*~)f lEt P ft,)tf 11 2 ) rrc t~ '/r, LL rh )~ 1~ IN -t [Q- A 4V t ~~ 1~ )k n A N * W 1~ t V11-c t *1 (3);K-M, r1l P4 (4)tX**, [tih)Q*jX-* rit n.* I A r7,, , f1l (5) V ff]A 1%, Y1W16t*9*01 Affl -L I ~S, T 11t%A #44 rp NRT4-*-1VAW1j -ANIM X,tT__Aj_tg f I W~4014K~5 I AWM I LN r] aAka ["OptnN, Fn ~P-Nm- 141 AM, IrAjol *kf I V-41T ~Yjy-f rNr~L, to*j~~ U t*g~AOXA m N 0 ~fi fmrT- N4q 01 MUM_ 41114fP N RN $Iq W11 If-M, N"m -A, ~,7- V)j- _11 ff, 1P tH -W i If W11 4 i f ~ m4# 31 A - T t i ~ If ~ Aq 01 f T-- A f n I m ?~,: Pi z I t- t MAO, XLAVP fa-AWTO, TN t0i* n,~fM-flA rT-§qfn #Lhkvmol~ Ail IUC- Ono, CA L# ff A jj M , In A , A ftg T,- A ffl Pn f4j)r,- Z-, Jiff- 0 W Jr T- m" 1w ft 104 a rv T to V 1*1 iN Xt,*, ~A, th 40 WLf-, ~T AAL,*, ~A, 1~- ---I FJ1 wf A- - 0, It it, WL, A q I a A, -L mf N R _q (~] fp).~t 4-L: #1)2-: &-' M. A 9M, f"i lyj 4~ Z-1 f N ~A N or w I A ~k (~] fur, -:f V xt it- 01 11 e -L 14 Lh T f fl ft V-111 ~A ~111 kk tWW, fill ~YOH A tt A LH- -Y~ A J~ Wj t r7- f Hft V11 4 A Ifi R -T- 4 y1j I A A #-,4 ~x -L A ~;h A Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 A T~ T- DIf IyIj j~ 81- f A fjL IM (i~ IV f aP, ~h I~L V t f P 4 4k ?II A m f1j, f fl V P fit a Ut t R f N I* Ox, t eff A (~Ij * H- I it IN 0- -1 XT JWII A MI 0- ;`-C XA It W9 r5~ R h -9 M, `C V TNE MP)OUM A r1i ijM V n M it Y q t2 $01 -1,- L t 911 kIHI T t M H MI 5E N MWkk*')C*PQ OqM "04 N*OF 4~PW Vi P11-6 '~~c I't fff 16 pj-r I N I 1P K M, ~~C:tjll~ vP Pj J-~- 9, N(TCM) M, M)A 3~ Z - , f P ~t -P il (MI, V ~fj- V,--) -4 4 V At M 4 Qq 1 Al it ffl MP rr #L A. ",~I jl~ f t A ? ", ",~EC x)j ji~ It W 16 x It DI W-)A A rk V, ~rj 2 0 0~HC Vj tr~i, ~Y ff L JT Wj f 4 W )~IA- - (D 3Z 9 L t A ~-L,% ~p T- (1) N ((-jl* F~ LA))t qi,L, ~,j ~c q * #ff j~ ~~,L,% ,%:0 1, ~~ 0, V, * W, Mpi Wgp, 4 0% (y w A ~2- t T m fyj Jul' 4-~ f 4, 4) f E 9 ft] 4 IA 3 ~ fj-r a , A V, ft I-E t T V rzll 9 ir'- ~A'q ~--,Vrj , ~t q * IM X'f )c a Ak 0, 3~ -T- -xt , ~t Ij m r, q L f '-I I tu 0' ;-t 4, L 0'' K y 11, ~P t a A, wq j~A ffiru PfYq Tiff nt RxL)(i H01,; WJ',tIE FL T MOEHAF k,~ MP Aa, /T, ~tVq A &Z,43, Atpm I H bv- RYU M~7- ji Hc*;#Y2'~'40' NTv'~~W'j A a-mc' 'g A -f fro If-, ~A 1) VA W11 11 Irr,14T "~T-~Llfm 75 1 M-Mul TIN Pf N VfFrf-u WL01 T:E N wIj 1P N %~A Kl~ 01 t01 ry W, M I It jL j fl T iA Hq A 4 IVIj & A IMM& ffl -:K tr~, * 0& A ) YJ tf L ~T f F 16. , r± % *m5F AL,-qf, lip 100029, 0 ff-k* q #LA I VA Yi- M W 16 If R ~+I , rP FA -~C Lz~ ffl -r j rpq t # I -T JTIJ V ft Xt 17 - 2 0"M %X,~ 2N!.f t T t 4 - Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 VL M, (EEG) ZMAV, 1)) 9113 2 A , Xf ffl, 9113 5 A . A ~~IrA M rr]i 4 V-f k~ +A X)J " 4 0 I a I~T-Ix A -[If/AH I, (f~ EEG A A, xfltO I Arf T AIX MR EEG f 2 0 H fn VA 4~ AiI it 3): K fff- r lit ff] 43 41 RE I-: ~ I - ~7- VL Mil i4 V ft If- ~Ycl 11 - ,, Hf, 0,~ffjgj tkfft III *T)Jrij Wj 0. 84± 0. 07 -LJTY 0. 87 0. 0 6, p 0. 0 5. *:t Til 0, AE Tf ft 9 #1 + W1 VM)~ 0 - 6 8 ± 0. 14; kt, It 0. 7 9 ±0-10;-V-M~tO.76±0-10. ±0. 12. P MXVI"T 0. 001. kl~, VJ - IrxtA~,ti rpkL UX-R rij h3fH Ii rm -aX'ft)'!'0fln4 . ~kXMJI* I ff [>-(.(F3-C3,F4-C4,C3-01,C4-02)M, t~ffffjtO~, :t ri 0 M i4 M A ljx~ f M, 91101 IN, m P, - & VQII i4 M4 A~ M LL , AL ~A ~t *a, X ~& R- ; XT M, 9110, A IMR] iA M A HA )Q MI EEG Mf,t,Mft, -A MR ~kj 14 * 4-t JK- j~j ff ~jfl M. ~rf Wj fffi, Fj 1-6 MT ff 4 :4,:,-Y, 40-Y, H 'Pill Z- /~c Vi 9 4- ~j M, I jq T'Y' V, ~j R -T- f 7- j~ -A (fvt 4-M ~x Xf T M HW-c It 0, Tq, A Z- y )-t A -W- A, V f 11 -ff RE xt N T 0, M), H f I: T Vr-AJflflNJ/ti!. IBVA Q 'M ~T ['~klij Ali-~ Bz ) al /T, yj A * M t m , V M WT $q, b)9 MI 5i _-! tz ) V- /T, u - N M, 0, , b -3t~ , A F-L , rh % N- xf HT % [Yj ~A- I ~k rp 01- Diq m T -PT 41F t _WP4 (0 MH A - rA- NL I V ~)Ijll :ivr 01 Iffi 11, 1 1 T- I% M, M. r-I M ~11 /-C IYIJ A 4h XA ~P , R f Fh 91: ~ 1- 0 M11 /L~- f X 0, -Mil ~t 9 L iltfff -L T+ I Lt HfI-rif OVAIM, yIj ~M-17'#R ~~ HTTM, X 26 % , AFLJM M 40 % , r"I HTNIN~ A 0, Hf %,V, M T 2. 47 9- ff 0, 4X-~~ /q M4 T go . fuRfl-PP~U)0qJ I-MAO, j&t- -q 3t~ PAfflfj,~ 1Hz A-T-1- fyj #k- AMD,, ffi t- ft M, 0, N't NI A4,8t ffiR, -Mij t~ . il " M A V-1,ft 5j~~, WM 2 ~a*90VVA 5 a C-L -6 xt rP , V f f I A A i9fli Z- 0 Vj 4K Z T- V Mq P, Wj, b *, ift t A HI, -0 , b -L 1~ T _L~-,pj_jFuIyIj&b I-' km Qij 11, Mf 10 f~ P ~,U r!,r 0, _L T+. ftj 22%,Affi-:-L)T-r 25Yo. /I . 5 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 1BV A p a 0, ~ 1-7 fig 6 -V,~,Y)~-r, f1j 6 :~;XfPqt3Rj:T 7 )~-6' HDBR ffil rn -fta TA-' In, Itf q WA, mmK- HA: 1. 7 6 - HDBR q 4V 2. CBF,SV,CO. U)JR141K, r,,jHjjP A LLBF,Rcbf/Rllbf,R.sv/Rllbf, SOD JZ~10--fXfH kl[,H MNCV PUL)IIIIXT 7 )~-6- HDBR Qa. 3. di ft R 8j , III-' Yt WA j~ I f V j!j* Fh 7 )~-6' HDBR r.)AO, 144 A HAR, A ~A 1-8 i~cl * Ift EE jg~ 4 - EE J~ Ail P J0qr,N#,k* It Wffl-IAKt, ~LJJX, 100083, FP Fq A 4 f 4, ff A rjd - , j L jp,~ 100094, MJV)C* 210008, 100081, VP ft f~ I A mbf W-R~ F~ fflaa n a A ~txv~cf't a fv~al~! f A-;5wv~ V-1 -910114-, - A A 2 Hz -F , V VM f L /1" nT (T A M IiK I * R , I nT = 10 9 T) Y11 10'nT. DC- 10KHz (aid MNit t DC- 1OHz); 20 A 38 AIX, 3~)~JMM, XfP~,?Jl 7 6 Approved For Release 2000/08/15 : CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 A ~51-1 It. WM--I-f'MXW BT I ~~d, 0, M-601 MV141VA a ~AH-A-Vii%+41., # M FJ *- TEAC ~~ 11, ffr I 3C VP Wr A- a 01 wrt 1~- It A t f H XT th i~- t A ~K P)j ~t r)j Hf,, & T- H,, F[J -1 /`Q, -ff nf Mil J~~ - f 41 a f 4 -9~: < 1 Hz, fi-i + fl m- T- I 'ffli -1 --,4- 9f A *11, H 1 9 IE It Richard H. Lee FP [4 fLIt * it,- VF I Ll~ P ,ff, _T~! M A A /TN L4-~ m W, * ~X- 9~ ~~-( fH `~C V] a A T t A m M, fik it A A T mi it 1~1 t4 1 S 9f fn 9w IyIj . MA, AL~A I-VAO VP ITM N * V"t I W 4 t 0 it 4 W11 AY MI 4a, IN ht 'At V- iK~ it f P) A M ffi 41 ~* AL A - It V -T- fil-, M, A /4", A N-1 I* -ki- ~A, ft t~ W I If, A f N : V /I N Wj A /11, i1 M- f* -PT a R J4 M 4~i Y- O~ -f- M, 0, k"- a 10~ fyj rki 9 9~ N . , b A 6JF 16 ~K HA , FE 4 UT A /11, il M- It, /IN; M 0 ft &, riE 0, Ak A A 41--- Hf, M M fm I ff -" PtIr.1k Y- iL IM14. 1%V00 )YUMNOM MIA 3-4 11 N--. t 11 01 ILC P~i Carl T 11 A A VF-:*: ~% Vj N. It T & *~ A a I A W~ M, rT T, 9 ii t -A )II I TM A W~ M, YJJ R /1, Ht, VJ,rk A 7~ /L C 41 N 9 LIT q ~ rm A ill- I E, )~ ffj Ail--: I Nf q V, -IT rf ej A j r-Ii j-IA !# W A)w 1 - 10 fital'. waru] RA, #A'Aij. 3f:W4I JUM FP L~ ff-zf4,)C* t 510089, IP Pq A 0 J6, -Y- E 9 At k- 4 r Vj- Wt rn R -i~ % q f fl if,, rY, Pwrtg 0, If ~IUJ- &, fti -Ar- f F ifl W, A m A - ~,9 r*- tj. * --~C ffl JX1 R q IA&, rT 6 4 lrj~ k,~, X)j ~rt ~ftJ 12 q X A fj ff 16, V TR N jt "-~ Vi iMl .7. Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 At ~gcw ad 64 HIR Lft;h Irn-- r-1 Of''Nq 5i~ Ilk fr] 0~ fr"', AIR f m, of t 17. 1±0. 4 Ik/ft* Wjft±f;T-,6-V51 -FM Vt 8. 2±0. 8nlm,%04'H t 12. 0±1. I &k/3~* 10. 6±0. 8 A% ~Prflt 9.7± 0. 9mm,%P-~'H t 16. 3± 1. 1 &/ft* , -LL* -'tiALIV, ff'i Vf, A4,30t IN, f0,VJj 01, 2~ %Iwrlten 19 ~-I -r-, T Wf It I Th, -JkI:tH If Irf OR f;~Vri~T%A 01 tfllul-l [R'%* A-Lr*j`C 20 M fff`~C -Pi I r1j'% 2 0 11-~ t T A - 5~ N i-f OT IR ii V Xf fr', A k%PqfrO,MflVUT,*- A12, t f ~ a -,t~ lyj w 16 0 t, 5,-K V A E, " b -4, f P /1, % A [Yi f" H n. t t VVEC ~ n. R-,% Ift , 1-k iI il /',, 10 m I (~,j ~V~ W Nt ~ 0 V' ~t M 1-k fff , ~K YX t A E, T Won #ffi i0ml WUM f 0 /11 % LI: -:-):J ~k !UZAa ii M ~I 4 ft 4 kQ -L fijr- Al I 9~1 YA HI, q x1f V t In 40 ~,A it RE ~~ I TI 25- Ff;~ T, No 0, A, P, W A f~ J-9 T rp] , -Pf RE -,j m 14 ~~ AL --6-f If IL=L:0 ifun %, ~1* A AM T, P f*) bVi fig PO IV' Nj M ft ffl n,, #L TV- UF 5Z -14M A*6 *, 3~ )A 0 ~g LXQ,r AW~, 610083, IP [M (~J,bKyt 4k; w P4 #, MY-2,U±fM. fVf1Xf 32 - 4 ?J1 (3 4 Xf M, 11 A N 19-1 1 SI,CI AC,HI -hj* f;T- ~I ~k I *:rf, it*~±Arl Rx,tAH (P0. 05 661 3A LN OF 4K 1. 882 0. 1. 72+0-59 2.28 <0. 05 578 A VT, )~ A 1. 719 0. 1. 56 0. 49 2.52 <0. 05 0,21% 607 V 9 1. 607 0. 1. 48 -1- 2.73 <0. 01 570 0. 43 it t, 1. 4900. 1. 340. 45 2.38 <0. 01 555 1. 578+ 0. 1. 46 0. 1.87 =0. 05 517 47 1. 3290. 1. 224-0. 1.98 <0. 05 450 43 1. 482+ 0. 1. 40 0. 47 1.30 >0. 05 514 1. 471 0. 1. 31 0. 36 3.58 <01 01 443 1. 620+ 0. 1. 45 0. 2.39 <0. 05 577 55 )j x1t TT t ly~ yIj f ~ M R ifl Ii t:~ m r"I a x1t LcoAr 911 V x1f M, 911 ATT ff ~6 LC VI 9R PE~ 8 9 A , ~,f P~ 9R)11~ 14 4 A 1. ,~9110 A 3~ftk- 22. 43% XfY~Qjj AM' fft,'~MIYJ-ff 3~R 51. 39%. M A M HA R, ~,f Pq, 911 . ,jg-L-,*O XI I 2. 3 0 f;T-, X2 = 17. 05 p,8 9*p*N:J~nk R+Q 9JJO, ARJ~,jft(X±SD) 9.2±2.5,Hq, 4~+Rg 2. 4). ~F fff R 9jjftMf, Fri 48-96 Wo&rr-0, CNE-2 -'j 2GgY #,t-~AfH~Of?Aq 01 -Pf 0-1 'It. 1-43 rP ffi K#)~*, J- 01, 510060, IP H +[Y,f~fft-:f-A(Pneumocystis Carinii '1% ftm PC )f~:~J:Z~Rg (AIDS) 0, A Awl t - E ~ I a J-~2 141 1 *% Af, --- 4E* lk 0 Tf-d -:f P, W -AYI- ( it ft" PCP) AVI I -L ~+jn PC ASWC *o t Wistar t -,IRWIR 150-200 AMW*,r 80 R,[V#Lftt A 911(26 R),B 911(28 R), C 911(26 q). A gli-Li B gflff~-fj ~h 4~X 15 ft*, N H -&,# 7 &. C gil ffl)~'& M"Vii: Irm 0 -PT O~ fk 4A FK 2 5mg T it If, , 4 A -- IX; A HfftA * rp tH ,,, k R Vq A'-ft Or X 0 IR 7 %), *J9A Tt, -1 ; Mp *,?k 1mg/ml 0, tk0t~-OfRR U %N 0 t f~l X J-1 A M-VVr:t 4-8 - fflt,~. ~Z fi, M A A ~,TL : E 911 R M T, H- V 9E - F 9 , f R W xt H 911 C 9114* 9 - F 9 Z t 0) 1 a, Wistar )QfX PC*,,, .28. Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 ~k I Wistar tA PC *M~J*& 2V 911 V1 rc PC(+) L94LWYO ) X, ftma A 26 17 65.4 A B p>O. 05 B 28 14 50.0 B C pO. 05. A-rM 4V4OT- i~jtvol L 3 10 AV ®R J 35. 4 )~, ~OtPq, 91110 R V MW 4VA + J~51 1VRj 11H] 30. 4 TzaX A t~ , M91i rEll P 0 - 0 5), Yff MY)i rij jE- 4 Q A IT :0 a ffi P* AL (P < 0 - 0 1 - 0 - 0 5) ; -ftL IN fitt M,, " VJ M A T- T * fA ~rt )~ 113 A (7 6. 0 7 Yo ) P* Y11 Y)W-l Wj 7 2 V4 (5 4. 9 6 Yo -ffi ff ~[j --::- M,L:rA Til A T T'k tj ~k 118 JYIJ (9 0. 0 7 Yo ) A A A h~i 7 5 Vq (5 7. 7 3 Yo ) p < 0. 0 1 X)j #, 41 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 f ft , -9 il H q 'Cot XI V L 4 A A T- & P) 4 P H , I W -14 I~Hc A f fl IWE A 9~~ U , A -n'~ fv-- It ft 4 n" P) 4 -T P H6 2-6 VJ -10 rT RJ-, t - ft AM J I SE, 3 0 fPj Corrado Bornoroni, Valerio Genitoni, Gilberto Gori, Giovanni Gatti, Antonio Dorigo OK * P,-E A 4 1 ~ L-- * R H P k f 4, * N * WJ F 16 t P" t f 11 M `~ECJAMW)~JMI NOH'WrlirT 30 4YqWA'tAJftLffi, , 93 20 /--, t 10 30 Ij 50 )'B Decoder 2000 P% FA t3f 1 OHz -Lffilofflnq Plit 0, -av r2-M 'W9. ~-- ZI~5v- H1,101j1hffil ~Jlt~ (~IjRmN;J-IxIt IM [b r-201 ~~A R ff. =3 2-7 AA TA -W if tA 3-~Xzt f944L* ANOW~CA*Y N PC I JLAM I W~ ffRIM ILI-qfl I + 19 *-~C M UA- 251 MI n 4~ t-Tjkffi-~ j~fF TP - 02 ~,f 37 -9911 A&FRI Am"If 01 WPU I Mr, WK RA : 1. A SBP, DBP f0 HR J~j ~~ H)j 2. 3*3f '9;-z H ", R~*'L=C, th *jf It ftb~qm-:-- gilz SBP,DBP ffl HR a J~-r 2-8 83 rig * A Aw rp K 1P NWIMANX MR I~Ult Ali!~' , 100091, rp IN IRA, A, 'ff W R#IAM n 1988 ~W 10 q -i~ 1992 V- 8 T 21 k 21 fq'~V)j 18 ~K 9 t,~ . V * Rx't W 6 8 ~V , fyL ?j' 20 N. ttNIj 93 11 #q, t 10 01]. 42 Approved For Release 2000108115: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/,15: CIA-RDP96-00792ROO0400430001-6 19 VP IN * ~k N f 14 Iff A t~~-, WT 3~ ff d, I rT '41:k f7T, it f n Vq M, C~'! m N M A jK [Yi W, ry,~"k Vr-, M, 53.3 A 76.6%. f~PAtXIFPTM"M' T MZ I- If, M, rT RE JR AT ~H tOA:k A , M H)P::C:rt ff", rT ~f MPA- IR A It T N i~v --A P Mi , fft 441 rr~ W, M r fA- M - A HI, rHI TL Jz ~~:~j 112 14 LP,' C -Tt VprT ~f ~rn" tff rN f~pl 9AI-[r[awft#T I -rryflqIV, fr"i tTTU~-,,J~ VQ T A IN It OOM~ 2-9 T IMAr *Mrb IN 9 rp H 2k 0 X PI-6 Irm w N fr- ~6 ff I IiIr jP 9q, ra- IK r1c * I J L I--rI I VP P T n N16EECA ~Y&XfML Av ~Kft%,t A-41 RE IY,1046 Rr-j , Rill 3~ M H#T, r"I 0~, jM, ft 11 W" -,V, T 3 0 +Jq Om rjEItI,:rj M A Y Hu m R M -I't A It RE (~ A A R P ~qftt~~prT 75±0.53mm, P=2.35±0.77mm(p:~ IP Will' )-I fYj 4WOJ4 29 A,r~ 92Yo. 3 k,& 8Yo. Afffq~tm ~,$, fYJ 3 0 M ~,t M 911 A A , ~W* ~~ a Iff A T P*, itt P'j "HE t~ T-,Mw')-T 7~ 11 1 Wr k rf ?,~, 18 A , r~ 61 Yo . N L~ * 3~ & -F 9 H)Ia,, WYN R /1~ -T 4 X I W/1,40A It M fR r ft Y- P~ A fff FP Wr rT ?1' 12 A , r~ 39% . p0. 05,,E a, (Ot" RE 1( 33 P1 I It, FP~Et 17 A, A ~~IA5rrl I Ct-,, ~Et ril- AV wffljll~~ If, JTE I I - gV11- -A )Carl ~Et:-L I* RE ~~ fly- f+ A (~Jwt PA. 10, 2,-, IV RE XtP rm IYNJ 'MrT 191MY-: 111" z- wi RA~11-rffj:P~T/Et. 1A 2 12 It- 30 Vjfml~r riElli~1*0AV& ::F ;kW,MT,-- A K 030002, FP PA MIXT 30 r)q-rr# AHiTV-K:AqO, FUM-V, -q (A 11 t 4 Pq JN T W ~fli' 6 Vf[]At* 30 jjrq Ojjfzj'q3~)~ : ~f *r*-AO, 10 fl) Pw M 10 10 vrl fl ~A nj] al W /1, 21 f9q Cyr-'V 13 r9fi0f' W Ji M rT 9 fLi*: 5 1F-'ffNk2f- (011 TKI rT-~NV) P A A 0 -A M kri 2 5 M h V[I'-rT ?J1, fK ffri * 4 flj-q * ~o~ M- T;~ A Y-j 5 V- ~J -L ifift ti't It ~y ff ft 1~r 1-4 5 V- ifi 19 * 5 r9d I '~-c JO M, rf xf ~JAi 0- A rr -Lj 4-by *- qw f ~- M ~-~k A H)j al T, I T -T- /* A 4t rrR jfl '% XJI'n)-T 911 1 5 &F-N -t tzilft* 4 IN, #~f A 4~0 A L&-KVT-nH1, Hi1f Ma,~-~M ILCA ifl, W * ','~ : x1t X 0 PA 0 14 "It W )m * 11~ )~ I M A 'd, w ( F)i Pq -A 4 M ) JE WH ft IS A It ~~ fl, & fT-, Yfl V ~Pz, WL, !"I- ~rj ~A I A L -7 N T A ~t rm A 0, A W I W,, rr A T T 41 tR , A 12 iR' ),~ PR AT 0, R R V L 4* M Rh A T~ A R Al. -q~ 1 11 r N~, 1 (4) It I R " 0 FE ji ~~- t 41 ji 2 - 13 41 WE MA'AM- 120 941181*1MMAR im 113 Lek 2 A I $ TT' 'P 'i N P~r~ I M t-q- Tif 1 2 5 5 0 6 7, FP III JZ iffi a VP vi Ek M fl,- M ~Y ffi~ V' 12 0 4#q frm)* RW4~ If )Y f~k A V, I A H)J T Ili N, f- /-C:)r] 45 - Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000108115: CIA-RDP96-00792ROO0400430001-6 :Ln, -Taig /=:-c it MIT- i1i FP A K MP n rVjrTQ riVMt (I ~m lit P-A FP Z V- N-Aq~ - flm)~ A, -W * X~f -L A QA)~If~- 99 R nj, ift A M gr il-~: WT ry n 11 ~ t Ti f] 0, 1* ~~ rT ~~ W, V, t t V 2-14 N q I 'Mrnrn ~tlf- A Ht4q W7 rm (MMA3~ffi , NIITArT Mif-, rT 1kA9rmrE 0 ilm rT 191k I t V j_;Jq, 9 /Rt 19E t f t 4, PW T~I- t 01 f ~ m - YN A A 0 t * 9114 0 fq 2P tj Y-,J 9~~ I rm ~*-, W W, X 4-A~, B 9 t/ao" -A, rVj ~T f H (AI) ~ M N J~ W)W i~~. A rP W 16 ~,t *, IPh E i~. A !~: 0, V] R *, WA WDAi V- j~ i* N ffi 4,- -t- -f- * K ~K 3 2 V4 ; $R Mw *)U` Y- a W 4 #4 -, f t rT -Tc ~A 2 Vq Fh:T I-L ~? _ffij ~'- I ~' !K a)' r ETCT,&MT4~'mry 2 jq. 6 1OM1,4)9-)9-rT&,-Pfi-VK 3-11rTf-q. 4±1- 3 MAWF: -'M 4a, *2~ R (P < 0. 0 5). b V, Xf P ki 1#1 rp, ry rij fr-,- 1-0 L A T HIf " f;T-, ~ q) W N A , f q 9,'- ~A ~t * A L A 1 -2 ~ J - A X (P > 0 0 5 ififf 911,110 ~n ~rn rr rUf"-- *, A f Il VT, FA R, N PT A ~Igtit*t~A 2~41k*a* (P<0. 01). ~--PL 2 2 %T fL JL41 IN 12- J~-~ A WJ kfrilrYA tiff P S 0, Vr-~A , AM 5-it-4-JR t 1. 2 % 2 - 15 n, ~ * " i,~ " n. 05K!* ry ;~ 10 Wtm- V * A R H Ai* Eh YA igffl 1-12 rfli Wir-1A. ~2 fHI A ~E A T * t -L 12,YC 01 *# t w ~m Ma P, 90 ~ fl, A 7 -WW'. * 46. Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 A-1piq Hq 441, 1-11'1~0* IIPLI - ~O)IUV k N ~~j K 0)] 51- r~j , 1~~ ~j ~h N V 4 )~ XT V, Wj , I~A " 't "t XT m M, f V N"'b" t xft M,n - Ml- - V., f9- -L L* tv IV, I A + q- * oj~ft) W, A * ik I E m JNI T - t I E M, e- 4 ~Ilj N Im- Kij 11, jv",~-c W11 F~ 1 ME- Mp LZ * IYJ ift I* KMri rT -M. ffi, b Y 1-1 1 ~KO, M - A J V- J1 y - k A J] t iL U 'Ut t FP, b ~t 17 6 8 JL A ON A- -A Ii N If ~Ij ML ji-m: A H *Aff A~~ P "~-CATf --nL- * : (1) IM 5 0 5 (A) F1 _)L, 541rjq, A~- --W '-116771 1~~ It, z I 4±~- Ir, I rm A Ix E Tft 04f V $R tW: M, m A0 xf ~~C Aik V, !E A A t Hr ;,-', VP 2-16 759IjII'1'u--T*Uff5E A j L FP N. * r1r, I A N, I rp 19 139 A , RYVL~~ )~-Fj 41 . A IP 75 AVW-~t)jk f14 rP 64 fd 7f~ffl *-q vP 1)-,-~ViiF V14VT /10 . *fKI An 1#1 11pi-N, W1 Y-A-IX I AYR 141, R, t-LL I lpvj-~gffl 30 ft~R. Ya, T-r, : `~X)j 911 HB.Ag M ff 2rAt 5 2. 6 Yo , Xt M 41 )(1 2 8. 8 Yo , p < 0. 0 1 ;%:0j hi HB,Ag M k * N a +- -5 A ~K * 4~-Ir,,~J73.3Yo,~tit,~,911.~AJ49.2Yo,p<0.01;"'CY)~~JIGPT,A/GY' --, -~k ' i lj~Trl/~MPILI- rPP,-MNYImtL LM, Af AM, YMV 'Miltit. - 47 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 2-17 It ~k2 31 fPjryj-RQO, M-11ft EEB~mi:~ T-VK An-im MM i~ -,T, WP N It OF 1z W, VF A, 2 5 0 014, 1P L-N A 1986 J-~Y 1990 V , ftFJ#LXT 197 04 ~:PZ* A LiEgAttz, rmWMr1#, Xf A-FP 31 rjqP,, XJ~Vj 1. f* A: Y~ru 24 rjqj1E A ILRf*:R-~Li M 2. 10. 19±3.29mmol/L OY 6.93+1.98mmol/L,p< 0.001. 3. 1h A'F:i: ng LM P ('I'C):)rj Fri B-,j fft F~ 6.75±1.32mmol/L 5. 51+1. 16mmol/L,p< 0.001. #A--!-AHI~(TG)F~ 2.80±1.Olmmol/L ~*Y 1.34±0.71mmo1/L,p<0.00j, 4. n.1h. Vf~jfl J~fftrh 16. 604±6. 005 MIU/L 12,62+14-85 MIU/L,p0.05)- SOD -TY-,JlAfU FL, 1(378-18±484-14u/gHb;t-T-ffl: 1704-3±572. 84u/gHb),ry-l~~4k #a, (p < 0. 0 1 %,:0 gli H)l R, A T * ~,T, JA~ t3, :ffi - , SOD SO D ~q R X t f ~ M 0, A 3~ ~f t t FO, I--: f ~ M T fjL f* F~ 9 X A Ffi 4. P,~, ~*,`c Xt ft AAA4jftL9Itj0, SOD R iff it A 44,5 9 C Vt- ~K 3-1- 1~ 0, f ~ ffl . A FP 0, t t V L $q ft % VT -,t~ M /,\, fF IL jt'L SOD MRM-TA ~tk Hf 2 - 2 i2 J-:4t -k)9 Tt, A M. rA,-'r. ~-A -1-634 rT,*, rIE- 8~, f* -t- rc,612164,rP[A IVA N I~VA rl~ 0 '41 hh N,~icxt ,A ~Ac V N m a mv I:P,' L-~ f E iA v,- m rT 'P N N P4 4; t AE 2 0 0 A 'gift 13 1 6 5. ~ 5 % 4 6 2 3 % 0 19 V ~ ( 9. 5 Yo ~A 4 V q ( 2 Yo 0, ~q -~Zt * 9 8 % T FP N 0, 'At -I- ,LR, A tin N JUT W 4 7 JIF)IJ .,6- AUHAM 117VU&A I A, -1kaff 4ULPA 50 Approved For Release 2000/08115: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 lei. 2 - 2 3 1-ji ry ff a Or, t'J IM'- 6 0 fPj rT Aj Q V,~ r')+1 Ir, W, )--J 1-)~. R-C z f# * Y- 4 ry a- -_iIr ~-)+I IP 114 6 0 VqW AUN A * 2 ~L, I CIA ITM ~~®rj ~* ~~c A FT t n~ q MI, HIf i~ It ~rl n E Ox kt, ~~( A VI & A I-T VPI M -'k * t 10 0 Yo ~ A A V Iq Mt 42 Pq (70% 10 ~-Tt(17% 8 JVI Wj 30 Iq ~ ', - , Mt 5-30 &,TJ~ 19 r Oz Adrl A* WJ~A it etr,-4(P~<'l ~-7 A STUDY OF THE POSSIBILITY OF PUSHING BLOOD FLOW TOWARDS THE HEAD AND CHEST IN THE LY- ING POSITION WITH THE HEAD ON A LOWER LEVEL DURING QIGONG EXERCISE Hou Shuli ,Liu Zhenxiu,Jiang Xiuyin,Yang Tangbin,Zhan Tingxiang Institute of Space Medico-Engineering, Beijing, China. 44"~ The paper discusses the general, physiological, biochemical and electroneurographical responses and the endurance time to tilt test during qigong exercise and the condition of the control group before, during and after HDBR (-6') for 7 days. The results are as follows. 1. HDBR (- 6') for 7 days played a simuled weightlessness part in short space flight. 2. Compared with the control group, CEF, SV, CO. of the qigong group decreased Sig- nificantly when they concentrated their minds on the lower limbs. At the same time, UBF Rcbf/Rllbf, R sv/ R llbf, the skin temperature of the lower dantian area and the gastrocne ~L mius muscle and the transcutaneous oxgen (TPO,) on the muscle increased significantly, The content of cortisol and aldosterone in urine and SOD in blood of the qigong group were better than the control group, and the latency of H reflex and the motor nerve conductive ve-, locity (MNCV) of the peroneus nerve of the qigong group were better than the control group. The endurance time and CID of the tilt test were significantly better than the control group. The general response of the qigong group during and after HDBR (- 6') for 7 days was, less than the control group. 3. From these results, we reach a conclusion that qigong can push blood flow towards the head and chest in the tying position with the head on a lower level during qigong exer- cise. At the same time, qigong can improve the physiological, biochemical systems, eleci troneurographical responses and the endurance time to tilt test. - 74 - Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 1 - 8 THE STUDY OF MAGNETIC SIGNALS UNDER THE QIGONG STATE BY SUPERCONDUCTING BIOMAGNE- TOMETER Wu Benlie Wang Xiubi * Wang Zijun Liu Jianben Dept. of Biophysics, Beijing Medical University, Beijing, 100083 *Institute of Somatic Science, Beijing, 100094 *Nanjing University, Nanjing, 210008 * *Institute of Geophysics, the State Bureau of Seismology, Beijing, 100081 In the previous article we finished a dynamic study of qigong (QG) magnetic signals (MS) by a flux-gate magnetometer in a magnetically shielded room. Under the QG state, MS was <2Hz in frequency and several nT (T=Tesla, the unit of magnetic flux density, InT=IC)-'T) in amplitude. In order to deeply understand the MS dynamic properties, hu- man weak MS was investigated by a superconducting biomagnetometer. In comparison with the flux-gate magnetometer, the superconducting biornagnetimeter is wider in frequency re- sponse (DC to 10KHz only DC to 1OHz in the flux-gate magnetometer) and higher in sensi- tivity. Through a frequency-power spectrum analysis by a computer, the MS changes under QG state can be analyzed quantitatively. 20 persons (38 tests) were selected as subjects, and divided into two groups. (1) The control group consisting of 3 persons did not practise qigong, 46. 3 years old in average; (2) The qigong group (practising for 1-20 years) consisted of 17 persons (31 tests) , 48. 3 years old in average. The subjects took off all magnetic things; then came into a magnetically shielded room, and the a~upoint to be measured aimingat -the probe., The distance between the probe and Laogong (P8) is about 6 cm, and that between the probe and head acupoints is about 4. 5cm. The MS dynamic changes were recorded continuously before, during and after QG state 0 minutes each). MS was measured by a superconducting biomagnetometer, Model M-601, and recorded by a tape recorder, Model MR-30C. (2. 4cm/sec in tape velocity). The frequency-power spectra were analyzed by a signal processor, Model 7T17-S. In this paper the power changes were all of relative values. The experimental results indicate that under the QG state three kinds of MS (0. 65 05 Obsessive-compulsive1.8820.598 1.720.59 2.28<0. 05 Interpersonal 1.7190.607 1. 560.49 2.52<0. sensitivity 01 Depression 1. 607 0. 57 1. 480.43 2. <0. 73 01 Anxiety 1. 490 0. 555 1. 34 0. 45 2.38<0. 05 Nostility 1. 578 0. 517 1. 46 0.47 1.871 ~0, 05 Phobic anxiety 1. 329 0. 45 1. 22 0. 43 1.981 <0. 05 Paranoid ideation1. 4820, 514 1. 40.47 1.3.>0. 05 Psychotism 1 1. 4910.443 1. 310. 36 3. <0. 58 01 Others 1 1. 62 0. 577 1. 450. 55 2.39<0. 05 The results of the research indicate that the group of exercising qigong for more than two years is lower than the group exercising qigong for less than two years on total scores, numbers of positive items,average positive items and ten factors scores. Statistic test gets re- markable level except somatization and paranoid ideation. The research results indicate that the longer people practise qigong the better their men- tal health is. ff . The role of qigong on type A behavior pattern 93 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 I studied the qigong group and the control group by a questionnaire of type A be- haviour pattern. There are 89 cases in the qigong group and 144 cases in the control group. My research results indicate that: 1. The qigong group f s percentage of type A behaviour pattern is 22. 43 percent. The control group's percentage of type A behavior pattern is 51. 39 percent. The qigong groupf s percentage of type A behavior pattern is remarkably lower than the control group. 2. Taking 30 scores as the standard,x' test of the result of qigong and the control group indicate that x'= 17. 05,P, 8 cells) under an inverted microscope was observed and counted. The mean value of cell clone (X±S. D. ) in the R + Q group was 9. 2 ± 2. 5, markedly lower than the R group Q 5. 8 ± 2. 4). There was a marked statistical difference (PO. 05 B 28 14 50.0 B C PO. 05 B 100 4. 98 0.4980 B C P>O. 05 C 100 4.74 0. 5326 A C P>O. 05 104 - Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 The experimental results suggest that the emitted qi reduces the infection rate and de- gree of Wistar rats by P. carinii. The emitted qi can inhibit the infection of P. carinii. ff . Nude mice were divided into two groups . Group A00) was injected of 5-8 X 10-'par- asites by lung innocubation. Group B were injected of parasites which had been treated by the emitted qi . The parasites were put into a small glass. A qigong master emitted his qi to the parasites 20 minutes and altogether 4 times. Each interval lasted for 48 hrs. The experimental results showed that 10 mice of Group A were infected by PC,in which 4 mice were of moderate infection degree,but in Group B only 6 mice were infected by PC, and all were of light infection degree. Two groups had big difference. 1-44 THE DOUBLE-BLIND TEST OF THE EMITTED Q1 ON TUMOR FORMATION OF A NASOPHARYNGEAL CAR- CINOMA CELL LINE IN NUDE MICE Chen Xiaojun`,Yi Qing('),Liu Kela('),Zhang Jinmei(",Chen Yu Sheng 13) Q)Cancer Center Sun Yat-sen University of Medical Sciences (2)Dept. of Physiology Sun Yat-sen University of Medical Sciences (3)Qigong Association of Guangdong, China Following the double-blind method,we carried out two experiments by using cell culture and nude mice. In the first experiment a qigong master treated the poorly differentiated na- sopharyngeat squamous cell carcinoma cell line (CNE-2) with his emitted qi followed by the inoculation of the treated cell (qigong group) and the untreated cells (control group) into 16 female nude mice (NC-Z strain mice). The results showed that the tumor formation of the treated cells was inhibited by an impressive rate of 100 yo (3/3). The same procedures were followed in the second experiment. The results demonstrated that the inhibiting rate was still 100%0/4). A pathological examination further confirmed that there were no tumor cells in the inoculating site of the qigong group whereas poorly differentiated squamous cell carcinomas were observed in tumor of the control group. No tumors were found in the livers and lungs of the mice in the qigong group. But in the control group of the first experiment 9 tumors metastasized to the lung in mouse 2. No tumors were found in the liver of mice in the first experiment or in the livers and lungs of the other mice . Although the mechanism of the effect of the emitted qi still remains unknown,the results of the present research reveals the necessity as well as the possibility of further investigating the inhibition of tumors and its mechanism. 105 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000108115 : CIA-RDP96-00792ROO0400430001-6 1-45 AN EXPERIMENTAL RESEARCH OF THE INFLUENCE OF THE EMITTED Q1 ON CANCER GROWTH, METAS- TASIS AND SURVIVAL TIME OF THE HOST Qian Shusen,Sun wei,Liu Qing,WanYi,Shi Xiaodong China Rehabilitaion Research Center,Beijing 100077,China In researches of the influence of the emitted qi on cancer growth, metastasis and survival time of host, 114 animal cancer, models were used in three batches. Tumor models were formed in mice by transplantation of U27 orM04cancer cells into subcutaneous tissues of the right armpit respectively. These mice with cancer cells were divided randomly into the qigong group and control group and all mice of the two groups were fed with same food. From the second day or seventh day after transplantation of cancer cells,the mice of the qigong group were treated for 10-30 minutes with the emitted qi every day,but the mice of the control group were not given any treatment. In experiment 1,on the 20th day after transplantation ot cancer cells,all mice of the two groups were killed and all tumor volumes were measured in- dividually. In experiment 2,on the 23rd and 33rd day after transplantation of'cancer cells,all mice of the two groups were killed and all armpit lymph nodes and lungs were taken out indi- vidually and examined histopathologically. In experiment 3,when the mice of the two groups died9their survival time after transplantation of cancer cells was calculated respectively. The following results were found. 1. In experiment I., the average tumor volume of the qigong group (31 mice, 2. 25 ± 5. 35cm')was obvioulsy lower than the control group(32mice,6. 32±10. 02cm'),P 0. 05). (4) The weight of brain of the stressed mice were lighter (20. 6±1. 5)than the non-stressed mice(22. 0±1. 4,pO. 05 about Chi- square test. Finally, to investigate 33 cancer patients after treatment, 17 of them died. They all but one died without suffering. It shows that IQG plays its role in euthanasia for the can- cer patients. It is certain,as a :result,that IQG is useful for treating tumor. The survivers live better, while the unsurvivers died without suffering. * 130 - Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 2-12 CLINICAL OBSERVATIONS ON 30 CASES OF CANCER TREATED BY QIGONG THERAPY Wang Ying No. 2 People's Hospital, Taiyuan, 030002, China We have observed 30 cancer cases treated by qigong for a long period. The 30 cases were divided into the following groups. (1)10 cases were examined by exploratory operation(among them 4 cases were under- gone radical opertion, 6 were not). All was treated by qigong therapy. (2)10 cases had been treated by radioactive, chemical therapy or supplementary treat- ment by Chinese herbal medicine and qigong treatment at the same time. (3) 10 cases were not indicated for operation, radioactive and chemical therepy. They were treated by qigong only. Method: (1) The emitted qi was used (including message water, message prescriptions and long distance qigong treatment). (2)Patients did qigong exercises by themselves. The result: Surviving over 5 years: 13 cases;tumor smaller in size: 21 cases;pain relief or disappearance: 25 cases. Case example. Luo Lin,a female deputy doctor in charge was examined and diagnosed to contract lung cancer. Then she was performed by a radical operation on August 15,1980. Three months lat- er,she began to do Guo Lin's qigong exercise. From then on metastasis was not seen. 2-13 CLINICAL IMAGE EXAMINATION TO SEE THE CURA- TIVE EFFECT OF 120 CANCER CASES TREATED BY CHINESE-WESTERN MEDICINE AND QIGONG THERA- PY Cong Jing,Lu Zhong Hospital Cong Jing Traditional Chinese Medicine, Zhibo, Shandong Province,Chi- na According to th e clinical image examination 120 cancer cases treated by Chinese-Western medicine and qigong therapy were investigated. This essay explains that (1) Guolin' s New Qigong Therapy is very effective to cancer; (2 )The curative effect of Chinese-Western medicine and qigong therapy is superior to any of qigong therapy or Chinese-Western thera- pies; (3)The rate of incidence of cancer diseases is high in the middle and aged males. There- fore,they should be examined frequently to make early diagnosis and early treatment. - 131 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 2- 14 TREATMENT OF ADVANCED GASTRIC CANCER IN THE AGED BY THE COMBINATION OF QIGONG AND MEDICINAL HERBS Fu Jingzhi The First Affiliated Hospital,Henan Medical University, Zhenzhou, China The purpose of this paper is to study the short-term curative effect of the therapy on ad- vanced cancer,the survival.quality and the effect produced by immunobiochemistry through the analysis of the curative effect of advanced gastric cancer of the old people treated by qigong together with medicinal herbs. Clinical information 1. Selection of cases: 40 patients in this group were all examined by gastroscope, X-ray, and ultrasonic exami- nation of B-scope and the diagnosis was confirmed with pathological and cytological examina- tions. Sex and age: Male, 32; female, 8; the ratio of male and female was 4 : 1. The age ranged from 60 to 80. Positions of pathological changes: Cardiac cancer -, 26 cases; cancer in the gastrobody; 6 cases; cancer of gastric antrum; 8 cases. Pathological types: Adenocarcin6ma, 18 cases; poor differentiated adenocarcinoma; 12 cases; mucous adeno- carcinoima;6 cases; signet-ring cell carcinoma; 4 cases. Subjects for research: 32 were patients with gastric carcinoma who lost the chance for operation because of their old age and weakness or because the disease that they suffered from belonged to the ad- vanced stage. 4 were patients who had recurrence after radical operation. 2 had no effect of chemotherapy. 2 were patients who had undergone chemotherapy and could not persistently accept the treatment because of serious side effect. 2. Method of treatment: The treating group was treated by qigong combined with herbs,developed and prepared as an anticancer drug known as "Weiliuping". The control group was only treated by "Weili- uping Results: 1. The relief of main symptoms There was significant difference between the two groups. (P0. 05). In the treating group,the index of immuni- ty obviously improved and the difference was significant. (P<0. 01). Discussion . The short-term effect of the treatment of advanced gastric cancer by qigong together with herbs "Weiliuping" , was satisfactory. (The effective rate was 22. 7 Yo ) The effect was better than that of "Tianxian pill" which was widely used to treat digestive tract cancer at home in recent years. (The effective rate is only 1. 2 Yo ). 2-15 FROM MEDICINE OF ORGAN TO MEDICINE OF FIELD 10-YEAR EXPERIENCE OF APPLICATION OF QIGONG TO MEDICAL PRACTICE Ryoichi Obitsu Obitsu Sankei Hospital,japan Western medicine proposes that human body mainly consists of organs,whereas the wis- dom of Chinese medicine teaches the importance of space within the body filled with various kinds of concept of elements and energy which endows us with knowledge to maintain the life and f orming the "field". This "f ield" has not been explained by physical science, but I estimate that it is neither composed of a single element like electricity nor magnetism. I would rather call it the "life field". Furthermore, if "qi" means the information which maintains the order of life, the field and "mind" means the expression of one of the elements of fields,it is obvious that there are three means in medicine;the one dealing with organs,qi,and mind. On this con- cept,for cancer treatment 1 have practised holistic medicine, applying Western medicine for organs,Chinese medicine for qi,and psychological treatment for mind. I will report the result in 1, 768 cases of cancer treatment especially qigong from Novem- ber 1982 to February 1993. Method: The patients of cancer were treated not only by Western medicine which is the most pop- ular treatment in Japanese medicine,but also with Chinese medicine which consists of herbs, acupuncture and moxibustionqqigong and diet,and psychological treatment which means re- laxation and image therapy. Qigong consists over 10 kinds of means like Fang-Song-Gong, Tai-Ji-Quan,Guo-Lin-Xin-Qi Gong,etc. Results: 1. It is difficult to express the result of my therapeutic treatment statistically as in West- ern science 9 because the treatment was not applied equally to each patients, but in various ways depending on to the symptoms of the cases. Calculating three-year survival rate in 505 - 133 - Approved For Release 2000/08/15: CIA-RDP96-00792ROO0400430001-6 Approved For Release 2000108115: CIA-RDP96-00792ROO0400430001-6 cases of cancer till January 1990,favorable result showed. G) In the grade 3 and 4. 103 cases (42. 7 Yo GiAn the end stage :185 cases(11. 9yo) 2. The number of the patients of cancer visiting my hospital is increasing year by year, 54 patients in 1983 to 677 cases in 1992. This fact shows that the holistic medicine is getting ac- cepted in Japan. Besides,cases wili be presented,which show you more in detail the contributing role of qigong in the treatment of cancer. 2-16 THE CLINICAL REPORT ON 75 CASES OF CHRONIC HEPATITIS B TREATED BY QIGONG Shen Fudao Hubei College of Traditional Chinese Medicine, Wuhan, China Since 1989,we have worked out a qigong set to nourish the liver according to the TCM principle "psychosomatic treatment". Meanwhile,we selected 139 cases of chronic hepatitis B which were divided into two groups at random according to the revised diagnostic and classi- fied criterion at the National Academic Conference on Virus Hepatitis held in Shanghai in 1990~ 75 cases were chosen to the experimental group which were treated by herbs and qigong. The other 64 cases treaded only by herbs belonged to the control group. 116 inpa- tients of the two groups were treated for more than 3 months;23 inpatients for 2-3 months and inpatients with less than two months was not selected to be observed. Each observation index was checked once each month until they left. The experimental group practised qigong 30 minutes each morning and evening. The result shows as follows:HBsAg negative rate of the experimental group was 52. 6% that of the control group was 28. 8% (P